Patents by Inventor William B. Adams

William B. Adams has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11911651
    Abstract: Embodiments of the presently described device, system and method support upper extremity therapy through a control device. In various embodiments, the control device is provided as a central hub with atomic elements extending outwardly thereof, and the control device can incorporate a movement interpretation circuit, a touch detection circuit and/or one or more sensory transducers. In various embodiments, the control device is interoperable with a valence, an external computing device and a display device. Embodiments of the external computing device are operable to render a graphical depiction of simulated objects in a virtual world upon receiving a transmission of sensed human grasping of one or more atomic elements.
    Type: Grant
    Filed: August 10, 2023
    Date of Patent: February 27, 2024
    Assignee: Barron Associates, Inc.
    Inventors: Richard J. Adams, William T. Gressick, Aaron B. Olowin, Matthew Lichter
  • Publication number: 20230000750
    Abstract: The inventive subject is directed towards ready-to-use topical cosmetic formulations that include at least one defensin present in sub-antimicrobially effective concentrations. Surprisingly, even at such low concentrations, defensins recruit LGR6+ stem cells from hair follicles to the interfollicular space. Including defensins in the inventive topical cosmetic formulations may reduce one or more of wrinkle depth, wrinkle length, wrinkle width, pore size, irregularity in texture of a skin surface, oiliness, brown spots, and red spots in non-injured skin, thus reducing apparent age.
    Type: Application
    Filed: September 9, 2022
    Publication date: January 5, 2023
    Inventors: Nikolay Turovets, William B. Adams
  • Publication number: 20230000751
    Abstract: The inventive subject is directed towards ready-to-use topical cosmetic formulations that include at least one defensin present in sub-antimicrobially effective concentrations. Surprisingly, even at such low concentrations, defensins recruit LGR6+ stem cells from hair follicles to the interfollicular space. Including defensins in the inventive topical cosmetic formulations may reduce one or more of wrinkle depth, wrinkle length, wrinkle width, pore size, irregularity in texture of a skin surface, oiliness, brown spots, and red spots in non-injured skin, thus reducing apparent age.
    Type: Application
    Filed: September 9, 2022
    Publication date: January 5, 2023
    Inventors: Nikolay Turovets, William B. Adams
  • Publication number: 20230000749
    Abstract: The inventive subject is directed towards ready-to-use topical cosmetic formulations that include at least one defensin present in sub-antimicrobially effective concentrations. Surprisingly, even at such low concentrations, defensins recruit LGR6+ stem cells from hair follicles to the interfollicular space. Including defensins in the inventive topical cosmetic formulations may reduce one or more of wrinkle depth, wrinkle length, wrinkle width, pore size, irregularity in texture of a skin surface, oiliness, brown spots, and red spots in non-injured skin, thus reducing apparent age.
    Type: Application
    Filed: September 9, 2022
    Publication date: January 5, 2023
    Inventors: Nikolay Turovets, William B. Adams
  • Publication number: 20220401337
    Abstract: The inventive subject is directed towards ready-to-use topical cosmetic formulations that include at least one defensin present in sub-antimicrobially effective concentrations. Surprisingly, even at such low concentrations, defensins recruit LGR6+ stem cells from hair follicles to the interfollicular space. Including defensins in the inventive topical cosmetic formulations may reduce one or more of wrinkle depth, wrinkle length, wrinkle width, pore size, irregularity in texture of a skin surface, oiliness, brown spots, and red spots in non-injured skin, thus reducing apparent age.
    Type: Application
    Filed: July 29, 2022
    Publication date: December 22, 2022
    Inventors: Nikolay Turovets, William B. Adams
  • Patent number: 11491096
    Abstract: The inventive subject is directed towards ready-to-use topical cosmetic formulations that include at least one defensin present in sub-antimicrobially effective concentrations. Surprisingly, even at such low concentrations, defensins recruit LGR6+ stem cells from hair follicles to the interfollicular space. Including defensins in the inventive topical cosmetic formulations may reduce one or more of wrinkle depth, wrinkle length, wrinkle width, pore size, irregularity in texture of a skin surface, oiliness, brown spots, and red spots in non-injured skin, thus reducing apparent age.
    Type: Grant
    Filed: December 19, 2016
    Date of Patent: November 8, 2022
    Assignee: MEDICELL TECHNOLOGIES, LLC
    Inventors: Nikolay Turovets, William B. Adams
  • Publication number: 20170157015
    Abstract: The inventive subject is directed towards ready-to-use topical cosmetic formulations that include at least one defensin present in sub-antimicrobially effective concentrations. Surprisingly, even at such low concentrations, defensins recruit LGR6+ stem cells from hair follicles to the interfollicular space. Including defensins in the inventive topical cosmetic formulations may reduce one or more of wrinkle depth, wrinkle length, wrinkle width, pore size, irregularity in texture of a skin surface, oiliness, brown spots, and red spots in non-injured skin, thus reducing apparent age.
    Type: Application
    Filed: December 19, 2016
    Publication date: June 8, 2017
    Inventors: Nikolay TUROVETS, William B. ADAMS
  • Patent number: 4020461
    Abstract: A system for transmitting digital information such as audio or video over a lossy or dispersive medium. The digital information is of the type where certain bits are more important than others and hence the less important bits can suffer a greater bit error rate. Accordingly, the most important bits are encoded into a (7,k) 8-ary Reed Solomon code where 7 is the length of the code and k is the dimension of the code. The less important bits are then respectively encoded into a (7,k+1) or a (7,k+2) 8-ary Reed Solomon code. The code words are modulated onto a plurality of tones or subcarriers. The decoding is effected by initially demodulating the subcarriers and generating a candidate set of code words from each 7-tuple of demodulated 8-ary symbols corresponding to a transmitted code word.
    Type: Grant
    Filed: November 18, 1975
    Date of Patent: April 26, 1977
    Assignee: TRW Inc.
    Inventors: William B. Adams, Douglas R. Anderson, Daniel D. Carpenter